Short answer
Danaher Corporation (DHR) filed an 8-K current report with the SEC on July 21, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Item 2.02 contains only a disclosure-status provision, not operating results or financial metrics.
Danaher Corporation 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Item 2.02 contains only a disclosure-status provision, not operating results or financial metrics
- The section is furnished rather than filed under Exchange Act Section 18, limiting liability and incorporation into other filings
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $6.3B, up 5.5%; GAAP net earnings $870M, up 60%, signaling strong operating leverage
- Adjusted EPS $1.94, up 8%; operating cash flow $1.5B and free cash flow $1.3B strengthened funding capacity
- Core revenue growth 3.0%, or 4.5% excluding respiratory testing, indicating healthier underlying demand
- Full-year adjusted EPS guidance raised to $8.45-$8.60 from $8.35-$8.55 following strong results and earlier Masimo acquisition completion
- StatLab acquisition expected by year-end 2026; ~$250M 2025 revenue, >85% recurring revenue, and first-year adjusted EPS accretion expected
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Danaher Corporation 8-K filings
Get the next DHR 8-K as it lands
Follow DHR for push alerts, or ask the research agent what this filing means.